ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: ARS Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: ARS Pharmaceuticals Inc
Rating: 1.123097125
Author: Trendlyne DVM scores

Weak Stock

about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...

8.40 0.10 (1.20%)

55.56% Fall from 52W High

896.7K

XNAS Volume

XNAS 06 Apr, 2026 3:51 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

11.3 / 100

Technically Bearish

34.1 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

1Yr Price target upside is 221%

6 analysts

ARS Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...

55.56% Fall from 52W High

SWOT Analysis

ARS Pharma Inc Live Price Chart